This information was published on 2026-06-15T07:28:21 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2657099 (IR 1918922) |
| (220) |
29 Apr 2026
|
| (300) |
US, 30 Oct 2025, 99471611
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of achondroplasia and hypochondroplasia. |
| (540) | JENRAYIS |
| (550) | Word |
| (730) |
Bridgebio Pharma, Inc.
|
Find out more about publications on the About page.